Affera Global Registry
Research type
Research Study
Full title
Affera Global Registry CIP A part of the Medtronic Cardiac Ablation (MCA) Post-Market Study Platform.
IRAS ID
335077
Contact name
Gregory Mellor
Contact email
Sponsor organisation
Medtronic Bakken Research Center B.V.
Clinicaltrials.gov Identifier
Duration of Study in the UK
8 years, 10 months, 17 days
Research summary
The purpose of this study is to collect clinical performance and safety data in a broad population of patients being treated with the Affera Platform device.
Participants will be treated following the same standard of care their study site would routinely follow when using the Affera Platform.
REC name
West Midlands - South Birmingham Research Ethics Committee
REC reference
25/WM/0130
Date of REC Opinion
15 Jul 2025
REC opinion
Further Information Favourable Opinion